Athanassios Fragoulis

Dr. Athanassios Fragoulis

Anatomy and Cell Biology, University Hospital RWTH Aachen, Aachen, North Rhine-Westphalia, Germany
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
CWChristoph Jan Wruck
Christoph Jan Wruck
Athanassios FragoulisAthanassios Fragoulis
Athanassios Fragoulis
AGAgata Gurzynski
Agata Gurzynski
LBLars-Ove Brandenburg
Lars-Ove Brandenburg
YKYuet Wai Kan
Yuet Wai Kan
TPThomas Pufe
Thomas Pufe
Objectives Increasing evidence suggests that oxidative stress may play a key role in joint destruction due to rheumatoid arthritis (RA). The aim of this study was to elucidate the role of nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that maintains the cellular defence against oxidative stress, in RA. Methods The activation status of Nrf2 was assessed in synovial tissue from patients with RA using immunohistochemistry. Antibody-induced arthritis (AIA) was induced in Nrf2-knockout and Nrf2-wild-type control mice. The severity of cartilage destruction was evaluated using a damage score. The extent of oxidative stress, the activation state of Nrf2 and the expression level of Nrf2 target genes were analysed by immunhistological staining. The expression of vascular endothelial growth factor (VEGF)-A was examined on mRNA and protein using the Luminex technique. A Xenogen imaging system was used to measure Nrf2 activity in an antioxidant response element-luciferase transgenic mouse during AIA. Results Nrf2 was activated in the joints of arthritic mice and of patients with RA. Nrf2-knockout mice had more severe cartilage injuries and more oxidative damage, and the expression of Nrf2 target genes was enhanced in Nrf2-wild-type but not in knockout mice during AIA. Both VEGF-A mRNA and protein expression was upregulated in Nrf2-knockout mice during AIA. An unexpected finding was the number of spontaneously fractured bones in Nrf2-knockout mice with AIA. Conclusion These results provide strong evidence that oxidative stress is significantly involved in cartilage degradation in experimental arthritis, and indicate that the presence of a functional Nrf2 gene is a major requirement for limiting cartilage destruction.

18 September 2015 in Clinical Science
Verified
Journal Article
Closed access
PDF file
OAOthman Al-Sawaf
Othman Al-Sawaf
TCTim Clarner
Tim Clarner
Athanassios FragoulisAthanassios Fragoulis
Athanassios Fragoulis
YKYuet Wai Kan
Yuet Wai Kan
TPThomas Pufe
Thomas Pufe
CWChristoph Jan Wruck
Christoph Jan Wruck
The transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) is a major regulator of oxidative stress defence in the human body. As Nrf2 regulates the expression of a large battery of cytoprotective genes, it plays a crucial role in the prevention of degenerative disease in multiple organs. Thus it has been the focus of research as a pharmacological target that could be used for prevention and treatment of chronic diseases such as multiple sclerosis, chronic kidney disease or cardiovascular diseases. The present review summarizes promising findings from basic research and shows which Nrf2-targeting therapies are currently being investigated in clinical trials and which agents have already entered clinical practice.

1 December 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NKNisreen Kweider
Nisreen Kweider
Athanassios FragoulisAthanassios Fragoulis
Athanassios Fragoulis
CRChristian Rosen
Christian Rosen
UPUlrich Pecks
Ulrich Pecks
WRWerner Rath
Werner Rath
CWChristoph Jan Wruck
Christoph Jan Wruck
Several recently published studies have suggested that decreasing VEGF levels result in placental oxidative stress in preeclampsia, although the question as to how decreased VEGF concentrations increase oxidative stress still remains unanswered. Here, we show that VEGF activated Nrf2, the main regulating factor of the intracellular redox balance, in the cytotrophic cell line BeWo. In turn, this activated the production of antioxidative enzymes thioredoxin, thioredoxin reductase, and heme oxygenase-1, which showed a decrease in their expression in the placentas of preeclamptic women. Nevertheless, this activation occurred without oxidative stress stimulus. As a consequence, the activation of Nrf2 protected BeWo cells against H(2)O(2)/Fe(2+)-induced oxidative damage. We further show that VEGF up-regulated the expression of itself. A positive feedback loop was described in which VEGF activated Nrf2 in an ERK1/2-dependent manner; the up-regulation of HO-1 expression by Nrf2 augmented the production of carbon monoxide, which in turn up-regulated VEGF expression. In conclusion, VEGF induces the Nrf2 pathway to protect against oxidative stress and, via a positive feedback loop, to elevate VEGF expression. Therefore, decreased VEGF bioavailability during preeclampsia may result in higher vulnerability to placental oxidative cell damage and a further reduction of VEGF bioavailability, a vicious circle that may end up in preeclampsia.

19 September 2016 in Glia
Verified
Journal Article
Closed access
PDF file
TDT. Draheim
T. Draheim
ALA. Liessem
A. Liessem
MSM. Scheld
M. Scheld
FWF. Wilms
F. Wilms
MWM. Weißflog
M. Weißflog
TCTim Clarner
Tim Clarner

1 August 2017 in Redox Biology
Verified
Journal Article
Open access
Athanassios FragoulisAthanassios Fragoulis
Athanassios Fragoulis
SSStephanie Siegl
Stephanie Siegl
Markus FendtMarkus Fendt
Markus Fendt
SJSandra Jansen
Sandra Jansen
USUlf Soppa
Ulf Soppa
CWChristoph Jan Wruck
Christoph Jan Wruck
There is increasing evidence for the involvement of chronic inflammation and oxidative stress in the pathogenesis of Alzheimer's disease (AD). Nuclear factor erythroid 2-related factor 2 (Nrf2) is an anti-inflammatory transcription factor that regulates the oxidative stress defense. Our previous experiments demonstrated that kavalactones protect neuronal cells against Amyloid β (Aβ)-induced oxidative stress in vitro by Nrf2 pathway activation. Here, we tested an in vivo kavalactone treatment in a mouse model of AD. The kavalactone methysticin was administered once a week for a period of 6 months to 6 month old transgenic APP/Psen1 mice by oral gavage. Nrf2 pathway activation was measured by methysticin treatment of ARE-luciferase mice, by qPCR of Nrf2-target genes and immunohistochemical detection of Nrf2. Aβ burden was analyzed by CongoRed staining, immunofluorescent detection and ELISA. Neuroinflammation was assessed by immunohistochemical stainings for microglia and astrocytes. Pro-inflammatory cytokines in the hippocampus was determined by Luminex multi-plex assays. The hippocampal oxidative damage was detected by oxyblot technique and immunohistochemical staining against DT3 and 4-HNE. The cognitive ability of mice was evaluated using Morris water maze. Methysticin treatment activated the Nrf2 pathway in the hippocampus and cortex of mice. The Aβ deposition in brains of methysticin-treated APP/Psen1 mice was not altered compared to untreated mice. However, methysticin treatment significantly reduced microgliosis, astrogliosis and secretion of the pro-inflammatory cytokines TNF-α and IL-17A. In addition, the oxidative damage of hippocampi from APP/Psen1 mice was reduced by methysticin treatment. Most importantly, methysticin treatment significantly attenuated the long-term memory decline of APP/Psen1 mice. In summary, these findings show that methysticin administration activates the Nrf2 pathway and reduces neuroinflammation, hippocampal oxidative damage and memory loss in a mouse model of AD. Therefore, kavalactones might be suitable candidates to serve as lead compounds for the development of a new class of neuroprotective drugs.

1 February 2016 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
PRPierluigi Ramadori
Pierluigi Ramadori
HDHannah K. Drescher
Hannah K. Drescher
SEStephanie Erschfeld
Stephanie Erschfeld
FSFabienne Schumacher
Fabienne Schumacher
CBCordula Berger
Cordula Berger
KSKonrad L. Streetz
Konrad L. Streetz